Galectin‐10 mRNA is overexpressed in peripheral blood of aspirin‐induced asthma
Authors:
Abstract
Background: In sensitive patients, aspirin is associated with nasal and bronchial inflammation, eliciting local symptoms. Although the disease is clinically well characterized, its physiopathology is incompletely understood and noninvasive procedures, allowing an effective distinction between aspirin‐induced asthma (AIA) and aspirin‐tolerant asthma (ATA) are missing.Objectives: The aims of the study were to compare AIA and ATA cohorts for clinical characteristics and to screen peripheral blood for differential mRNA expression.Methods: Patients experiencing symptoms following aspirin ingestion were considered as aspirin sensitive. Peripheral blood was collected to quantify mRNA expression, using microarray technology and quantitative RT‐PCR.Results: Data indicated that AIA and ATA share large number of similarities for clinical phenotype. Screening of mRNA expression using microarray showed an overexpression of galectin‐10 mRNA in AIA (AIA/ATA ratio = 1.9, P < 0.05). Results were confirmed using qRT‐PCR. A positive correlation was established between microarray and qRT‐PCR results for galectin‐10 mRNA expression (r = 0.92, P < 0.0001). Finally, qRT‐PCR results were validated on a subset of asthmatics and controls, showing an increased expression of galectin‐10 mRNA in AIA vs ATA (P < 0.001) and vs controls (P < 0.01).Conclusions: Our results demonstrate that AIA and ATA remain difficult to distinguish using clinical criteria. Employing two molecular biological methods, we demonstrate that galectin‐10 mRNA is overexpressed in AIA, suggesting a novel candidate gene and a potentially innovative pathway for mucosal inflammation in aspirin intolerance.Keywords
This publication has 39 references indexed in Scilit:
- Comparison of Plasma Eotaxin Family Level in Aspirin-Induced and Aspirin-Tolerant Asthma PatientsChest, 2005
- Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthmaJournal of Allergy and Clinical Immunology, 2005
- Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shockClinical Immunology, 2005
- Critical Role for Galectin-3 in Airway Inflammation and Bronchial Hyperresponsiveness in a Murine Model of AsthmaThe American Journal of Pathology, 2004
- affy—analysis of Affymetrix GeneChip data at the probe levelBioinformatics, 2004
- Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problemsJournal of Molecular Endocrinology, 2002
- Isolation and Characterization of a Novel Eosinophil-specific Galectin Released into the Lungs in Response to Allergen ChallengeJournal of Biological Chemistry, 2002
- A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonistJournal of Allergy and Clinical Immunology, 1998
- The atopy trait in hypersensitivity to nonsteroidal anti‐inflammatory drugsAllergy, 1996
- Crystal structure of human Charcot–Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectinsStructure, 1995